Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.


These articles are all highly relevant diabetes. I believe this information can help you understand diabetes's professional information. If you want to know more, you can contact us at any time, we can provide you with more professional guidance.
  • Market Expansion: Dapagliflozin Receives FDA Approval for Treating Type 2 Diabetes in Children


    AstraZeneca has announced on June 12, 2024, that Farxiga (dapagliflozin) has been approved by the U.S. Food and Drug Administration (FDA) for improving glycemic control in children aged 10 years and above with type 2 diabetes (T2D). The FDA approval is based on the positive results from the Phase 3 Read More
  • The Growing Global Burden of Diabetes


    November 14th marks World Diabetes Day, a day to raise awareness of the impact of diabetes globally. This year's theme is "Access to Diabetes", focusing on the importance of knowing your risk for type 2 diabetes and ensuring access to proper information and care. In honor of World Diabetes Day 2023, Read More